Indications
Female contraception. Evra is intended for women of fertile age. The safety and efficacy has been established in women aged 18 to 45 years.
Composition
- Active substance
- norelgestromin, Ethinyl estradiol
- International name (INN)
- norelgestromin;ethinyl estradiol
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Evra
- Active substance
- norelgestromin, Ethinyl estradiol
- ATC code
- G03AA13
- Therapeutic area
- Contraception
- Marketing authorisation holder
- Gedeon Richter Plc.